Cochrane Database Syst Rev
A great time to quit: Smoking cessation while hospitalized
May 24, 2024
![card-image](https://cdn.epocrates.com/specialty/fhevtoe66bch/5UXJZFBaE1Ooa5wccwX7Gt/5c222734be61f3451389beececb66b32/Interventions.jpg)
Offering smoking cessation during hospitalization—and continuing it for at least a month post-discharge—upped quit rates compared with no hospital intervention, according to this meta-analysis.
- This analysis reviewed 82 studies (74 were RCTs) including 42,243 hospitalized patients. Psychiatric and substance abuse center patients were not included. Abstinence at 6 months or greater post-intervention was the primary outcome; biologically-validated results were used when available.
- Inpatient-only counseling, without post-discharge continuation, may modestly impact quit rates, though evidence is less certain than for interventions that began in-hospital and continued support after discharge.
- Nicotine replacement therapy was superior to placebo or no pharmacotherapy, per high-certainty evidence. Varenicline also supported quitting, compared with placebo or no pharmacotherapy, per moderate-certainty evidence. However, evidence on bupropion was of low certainty.
Source:
Streck JM, et al. (2024, May 21). Cochrane Database Syst Rev. Interventions for smoking cessation in hospitalised patients. https://pubmed.ncbi.nlm.nih.gov/38770804/
TRENDING THIS WEEK